1. Home
  2. FIHL vs SLNO Comparison

FIHL vs SLNO Comparison

Compare FIHL & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidelis Insurance Holdings Limited

FIHL

Fidelis Insurance Holdings Limited

N/A

Current Price

$18.74

Market Cap

2.0B

Sector

N/A

ML Signal

N/A

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

N/A

Current Price

$36.65

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FIHL
SLNO
Founded
2014
1999
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
FIHL
SLNO
Price
$18.74
$36.65
Analyst Decision
Hold
Strong Buy
Analyst Count
7
11
Target Price
$22.50
$108.00
AVG Volume (30 Days)
445.4K
1.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.21%
N/A
EPS Growth
N/A
108.90
EPS
N/A
0.39
Revenue
N/A
$1,450,788.00
Revenue This Year
$16.34
$155.44
Revenue Next Year
$7.05
$57.99
P/E Ratio
N/A
$94.31
Revenue Growth
N/A
138.82
52 Week Low
$14.67
$32.63
52 Week High
$20.50
$89.12

Technical Indicators

Market Signals
Indicator
FIHL
SLNO
Relative Strength Index (RSI) 41.59 38.45
Support Level $18.56 $32.63
Resistance Level $19.05 $44.60
Average True Range (ATR) 0.53 2.31
MACD -0.12 0.09
Stochastic Oscillator 26.23 41.12

Price Performance

Historical Comparison
FIHL
SLNO

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: